Kezar Life Sciences, Inc.【KZR】 利益剰余金の推移
機能の使い方
|
（単位：千ドル）
|
利益剰余金
|
前年比（％）
|
|
1Q25
|
-451,100
|
+21.1%
|
|
4Q24
|
-434,500
|
+23.9%
|
|
3Q24
|
-414,300
|
+30.1%
|
|
2Q24
|
-394,000
|
+33.4%
|
|
1Q24
|
-372,400
|
+37.4%
|
|
4Q23
|
-350,800
|
+40.9%
|
|
3Q23
|
-318,500
|
+38.1%
|
|
2Q23
|
-295,400
|
+38.8%
|
|
1Q23
|
-271,100
|
+37.8%
|
|
4Q22
|
-248,900
|
+37.7%
|
|
3Q22
|
-230,700
|
+38.6%
|
|
2Q22
|
-212,900
|
+40.1%
|
|
1Q22
|
-196,700
|
+41.5%
|
|
4Q21
|
-180,700
|
+43.4%
|
|
3Q21
|
-166,400
|
+44.6%
|
|
2Q21
|
-152,000
|
+46.4%
|
|
1Q21
|
-139,000
|
+47.4%
|
|
4Q20
|
-126,000
|
+49.5%
|
|
3Q20
|
-115,100
|
+54.1%
|
|
2Q20
|
-103,800
|
+58.3%
|
|
1Q20
|
-94,300
|
+65.9%
|
|
4Q19
|
-84,300
|
+71.4%
|
|
3Q19
|
-74,703
|
+72.1%
|
|
2Q19
|
-65,555
|
+73.7%
|
|
1Q19
|
-56,837
|
-
|
|
4Q18
|
-49,195
|
-
|
|
3Q18
|
-43,413
|
-
|
|
2Q18
|
-37,750
|
-
|